Viracta Therapeutics (VIRX) Stock Chart & Stock Price History $0.0098 0.00 (0.00%) As of 07/24/2025 Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Viracta Therapeutics Stock Price Performance The Viracta Therapeutics (VIRX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 97.99%, with a year-to-date return of -93.92%. In the past month, the stock has decreased 38.88%, reflecting recent market activity. As of the latest close, Viracta Therapeutics traded at $0.01 with a market cap of $389 thousand and volume of 0 shares. Receive VIRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Viracta Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day PerformanceN/A1 Month Performance-38.88%3 Month Performance-55.55%Year-To-Date Performance-93.92%1 Year Performance-97.99% VIRX Stock Chart for Friday, July, 25, 2025 VIRX Chart by TradingView Viracta Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/17/2025$0.01$0.01$0.01$0.01484,026 shs$389,000.0007/16/2025$0.01$0.01+2.08%$0.01$0.01484,026 shs$389,000.0007/15/2025$0.01$0.01-4.95%$0.01$0.012.64 million shs$382,000.0007/14/2025$0.01$0.01-8.18%$0.01$0.01242,205 shs$401,000.0007/11/2025$0.01$0.01-18.52%$0.01$0.01313,216 shs$437,000.0007/10/2025$0.01$0.01-6.25%$0.02$0.01150,176 shs$537,000.0007/09/2025$0.01$0.01$0.01$0.01228,329 shs$572,000.0007/08/2025$0.02$0.01-7.10%$0.02$0.01261,450 shs$572,000.0007/07/2025$0.02$0.02-4.32%$0.02$0.0272,034 shs$616,000.0007/04/2025$0.02$0.02$0.02$0.0231,733 shs$644,000.00 Get the Latest News and Ratings for VIRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Viracta Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/03/2025$0.02$0.02+1.25%$0.02$0.0231,733 shs$644,000.0007/02/2025$0.02$0.02-2.44%$0.02$0.0224,991 shs$636,000.0007/01/2025$0.02$0.02-1.20%$0.02$0.023,593 shs$652,000.0006/30/2025$0.02$0.02-6.74%$0.02$0.02709,325 shs$660,000.0006/27/2025$0.02$0.02+11.95%$0.02$0.0262,817 shs$707,000.0006/26/2025$0.02$0.02-0.62%$0.02$0.02138,039 shs$632,000.0006/25/2025$0.02$0.02+1.91%$0.02$0.0265,792 shs$636,000.0006/24/2025$0.02$0.02-3.09%$0.02$0.0270,796 shs$624,000.00 Related Companies ADXS Stock Price Chart SLRX Stock Price Chart BPTH Stock Price Chart ATXI Stock Price Chart TNFA Stock Price Chart ASLN Stock Price Chart OGEN Stock Price Chart EVFM Stock Price Chart NMTR Stock Price Chart TRVN Stock Price Chart Receive VIRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Viracta Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VIRX) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viracta Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viracta Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
